focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0199
Bid: 0.0182
Ask: 0.0198
Change: 0.0007 (3.65%)
Spread: 0.0016 (8.791%)
Open: 0.0185
High: 0.0199
Low: 0.0185
Prev. Close: 0.0192
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Executive Board Appointments

13 Aug 2021 07:00

RNS Number : 5737I
Supply @ME Capital PLC
13 August 2021
 

13 August 2021

Supply@ME Capital plc

(The "Company" or "SYME")

 

Thomas James and John Collis appointed as SYME Executive Directors

 

Following the recent successful completion of the acquisition of TradeFlow Capital Management Pte Ltd. ("TradeFlow"), and the Company's 2020 Annual General Meeting held on 30 July 2021, Supply@ME Capital plc, the innovative fintech platform which provides the Inventory Monetisation© service to manufacturing and trading companies, is pleased to confirm the appointments of Dr Thomas James and Mr John Collis to the Board of the Company as Executive Directors.

 

Dr James and Mr Collis will continue in their current executive roles, leading the TradeFlow business.

 

The following information is disclosed pursuant to the QCA Corporate Governance Code and best practice:

 

Thomas Glyn James (Tom James) (aged 49) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

TradeFlow Capital Management Pte Ltd.

NR Capital Pte Ltd.

Skybird Records Ltd.

Navitas Resources Capital Ltd

Commodity Partners International Ltd.

TradeFlow Capital Management Systems Pte Ltd

Tijara Pte Ltd

Navitas Resources (UK) Ltd. (Dormant)

Navitas Resources Pte Ltd. (Dormant)

 

Dr. James currently holds 406,500,000 Ordinary shares in the Company.

 

John Charles Collis (aged 51) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

TradeFlow Capital Management Pte Ltd.

NR Capital Pte Ltd.

Kenwood Secretaries Ltd

International Knowledge Ltd

TradeFlow Capital Management Systems Pte Ltd

Navitas Resources Capital Ltd

Tijara Pte Ltd

Kenwood Nominees Ltd

JCS 110 Ltd

Higher Education Research Ltd

English Pocket Opera Company

MTI Solutions Ltd

JCS 105 Ltd

Ultraponix Ltd

Price Verifier System Ltd

SoftNPower Ltd

JCS 107 Ltd

 

 

 

Mr Collis currently holds 406,500,000 Ordinary shares in the Company.

 

There is no further information on either Director to be disclosed pursuant to The LSE Standard Listing Rulebook.

 

Notes

Supply@ME enables businesses to generate cashflow, via a non-credit approach and without incurring debt, by monetising their existing stock which the business intends to sell to the end-customers or goods/ commodities part of a typical import/ export transaction. SYME' Global Inventory Monetisation Fund enables strong companies to improve their working capital cycle. The funds do not monetise inventory for companies in financial difficulty or with inventory that they are struggling to sell.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGUGDILXBDGBX
Date   Source Headline
13th Aug 20217:00 amRNSExecutive Board Appointments
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:36 pmRNSPrice Monitoring Extension
12th Aug 20212:05 pmRNSSecond Price Monitoring Extn
12th Aug 20212:00 pmRNSPrice Monitoring Extension
10th Aug 20217:00 amRNSAppointment of David Bull to the Board
9th Aug 20217:00 amRNSLaunch of Global Inventory Monetisation Fund
30th Jul 20214:00 pmRNSResult of AGM
29th Jul 20214:40 pmRNSSecond Price Monitoring Extn
29th Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jul 202111:01 amRNSIssue of Equity; CLN Restructuring; Notice of TU
22nd Jul 20217:00 amRNSBoard Changes
6th Jul 20217:00 amRNSCompletion of Acquisition & Board Restructuring
5th Jul 20217:00 amRNSNotice of 2020 AGM
29th Jun 20217:00 amRNSCaptive Bank Funding Strategy Update
28th Jun 20217:00 amRNSPublication of 2020 Annual Accounts
16th Jun 20212:49 pmRNSIssue of £5.6million Convertible Loan Notes
4th Jun 20217:00 amRNSUpdate on Publication of 2020 Annual Accounts
26th May 20217:00 amRNSAcquisition Update
30th Apr 20212:41 pmRNSResult of AGM
23rd Apr 20217:00 amRNSFinancial Calendar Update
19th Apr 20217:00 amRNSAcquisition Update
14th Apr 20212:06 pmRNSSecond Price Monitoring Extn
14th Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20217:00 amRNSNotice of 2019 AGM
1st Apr 20219:05 amRNSSecond Price Monitoring Extn
1st Apr 20219:00 amRNSPrice Monitoring Extension
1st Apr 20217:00 amRNSTrading Update
19th Mar 20217:00 amRNSTransaction Update
17th Mar 20217:00 amRNSAcquisition
9th Mar 20213:09 pmRNSRestoration of Listing and Resumption of Dealings
16th Feb 20217:00 amRNSUpdate on Restoration of Listing
4th Feb 20218:00 amRNSUpdate on Relisting
29th Jan 20217:15 amRNSInterim Results for the 6 months to 30 June 2020
28th Jan 20217:00 amRNSStatutory Audited Accounts to 31 December 2019
21st Jan 20217:32 amRNSTemporary Suspension
20th Jan 20217:00 amRNSShariah Compliant Platform officially approved
19th Jan 20217:00 amRNSChange of Accounting Reference Date
11th Jan 20217:00 amRNSNew Co-Operation Agreement
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
31st Dec 202011:06 amRNSSecond Price Monitoring Extn
31st Dec 202011:00 amRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSInventory Funding: Year-End Update
29th Dec 20207:25 amRNSHolding(s) in Company
29th Dec 20207:25 amRNSDirector/PDMR Shareholding
29th Dec 20207:25 amRNSHolding(s) in Company
29th Dec 20207:25 amRNSDirector/PDMR Shareholding
24th Dec 20207:00 amRNSNew Investment in SYME
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.